Search

Search compounds, pages, and insights

Editorial close-up of dried botanical ingredients accompanying Phyto-Medichem perspectives
Insights

Phyto perspectives.

Long-form pieces from our manufacturing, sourcing, and quality teams on standardisation, chain-of-custody, and the regulatory landscape for botanical ingredients.

Filter
Featured

Featured article

Kanna: what the new pharmacology says
Compound Profiles

Kanna: what the new pharmacology says

Sceletium tortuosum spent decades as a niche ethnobotanical. New pharmacology has moved kanna into mainstream mood and cognitive formulations.

May 20267 min read
Latest articles

Latest articles

Compound Profiles

Tongkat ali: eurycomanone and adulteration

Tongkat ali is heavily traded and heavily adulterated. Here's how the supply chain distinguishes pharmaceutical-grade material from the rest.

April 20267 min read
Manufacturing

'Standardised': what it really means

'Standardised' is the single most-overused word in the botanical-ingredients industry. What it should mean — and what to look for on a CoA.

March 20266 min read
Sourcing

Direct-from-grower: chain of custody

Botanical supply chains are notoriously layered. Why direct grower partnerships matter, and what a genuinely documented chain-of-custody looks like.

February 20267 min read
Quality

GACP, GMP, HACCP: what each covers

Three acronyms that show up on every botanical-ingredient quality page. What each actually covers, and where the boundaries between them sit.

January 20265 min read
Compound Profiles

Noble kava: the export-grade chemotype

Noble kava is one of the most cultivar-sensitive botanicals in trade. What the kavalactone chemotype measures, and how we evaluate material at intake.

December 20256 min read
Upcoming webinar

Navigating global regulatory pathways for botanical ingredients.

Join our regulatory experts for a comprehensive overview of approval pathways across key markets — Thailand, EU, USA, and ASEAN.

25 January 202614:00 GMT+7
Register now